Market News

Follow the latest financial and economic news, market updates, reports, and analysis on PipVero.

Source: PRNewsWire News Agency
1 month ago
Stock Medium Importance
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

Related Symbols 1
PRCT PRCT
Source: PRNewsWire
Visit Source
0 0 0
Read More
Comment
Source: Zacks Investment Research News Agency
1 month ago
Stock Medium Importance
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.28 per share a year ago.

Related Symbols 1
TXG TXG
Source: Zacks Investment Research
Visit Source
Official Partner ITBFX Start Trading
0 0 0
Read More
Comment
Source: Zacks Investment Research News Agency
1 month ago
Stock Medium Importance
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago.

Related Symbols 1
HALO HALO
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment